International Journal of Endocrinology
Volume 2017, Article ID 4138783, 8 pages
https://doi.org/10.1155/2017/4138783
Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
1Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
2Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Correspondence should be addressed to Sarah Zaheer; ude.dravrah.hwb@reehazs and Anand Vaidya; ude.dravrah.hwb@aydiavdnana
Received 19 April 2017; Accepted 31 May 2017; Published 20 July 2017
Academic Editor: Nicolas Verheyen
Copyright © 2017 Sarah Zaheer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [2 citations]
The following is the list of published articles that have cited the current article.
- Nicolas Verheyen, Martin R. Grübler, Andreas Meinitzer, Christian Trummer, Verena Schwetz, Karin Amrein, Hans P. Dimai, Winfried März, Cristiana Catena, Dirk von Lewinski, Jakob Voelkl, Ioana Alesutan, Astrid Fahrleitner-Pammer, Helmut Brussee, Stefan Pilz, and Andreas Tomaschitz, “Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism – The randomized, placebo-controlled EPATH trial,” Bone, 2017. View at Publisher · View at Google Scholar
- Lise Sofie Bislev, Lene Langagergaard Rødbro, Jesper Nørgaard Bech, Erling Bjerregaard Pedersen, Lars Rolighed, Tanja Sikjaer, and Lars Rejnmark, “Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial,” Clinical Endocrinology, 2018. View at Publisher · View at Google Scholar